Abstract View: 3364
PDF Download: 1533
COVID-19
Review
Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement
Mojtaba Malek
1 
, Farhad Hosseinpanah
2 , Hamid Reza Aghaei Meybodi
3 , Seyed Adel Jahed
4 , Farzad Hadaegh
5 , Sasan Sharghi
3 , Alireza Esteghamati
6 , Mohammad E. Khamseh
7* 1 Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology & Metabolism, Iran University of Medical Sciences, Tehran, Iran
2 Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Endocrinology and Metabolism Research Institute (EMRI) Tehran University of Medical Sciences (TUMS), Tehran, Iran
4 Gabric Diabetes Education Association, Tehran, Iran
5 Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 Endocrine Research Center, Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran
7 Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran
*Corresponding Author: *Corresponding Author: Mohammad Ebrahim Khamseh, MD; Endocrine Research Center, Institute of Endocrinology and Metabolism, No. 10, Firoozeh St., Valiasr Ave., Vali-asr Sq., Tehran Iran. Tel: +98-21-88945172, Fax: 98-21-88945173, Email: , Email:
khamseh.m@iums.ac.ir
Abstract
The coronavirus infection is an evolving pandemic with high morbidity and mortality, especially in people with comorbidities. The case fatality rate (CFR) is 9.2% in the presence of diabetes, while it is 1.4% in those without any comorbidity. Diabetes is a prevalent disease globally; hence, healthcare professionals are highly concerned about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic progression. Current evidence does not support higher incidence of coronavirus disease 2019 (COVID-19) in people with diabetes (PWD). However, people with diabetes are considered high risk for developing complications. Optimal metabolic control is a challenging concept, especially in the presence of an acute and severe respiratory viral infection. In this consensus, we considered the challenging issues in management of patients with diabetes during the COVID-19 pandemic. The consensus covers various aspects of outpatient as well as inpatient care based on the current evidence.
Cite this article as: Malek M, Hosseinpanah F, Aghaei Meybodi HR, Jahed SA, Hadaegh F, Sharghi S, et al. Diabetes management during the COVID-19 pandemic: an Iranian expert opinion statement. Arch Iran Med. 2020;23(8):564–567. doi: 10.34172/ aim.2020.61.